Gmtatnicin ototoxicity and nephrotoxicity were compared in two strains of rats. Sprague-Dawley and Fisher-344. and in the Hartley albino guinea pig. Treatment groups consisting of 8 male rats of each strain and four male guinea pigs were dosed subcutaneously for 14 days with either 80 or 100 mg/kg of gentamicin sulfate in saline. Brainstem auditory evoked response (BAER) thresholds were recorded from each animal in each group on day 11 post-administration.
Introduction
The guinea pig and chinchilla have been used extensively in behavioral, physiological and morphological studies of the mechanisms of hearing loss (Hawkins, 1976) . In ototoxicological investigations, the rat may offer certain advantages over the guinea pig and chinchilla. The rat is easier to breed and less expensive than either the guinea pig or the chinchilla. Furthermore, the rat is the animal most widely used in toxicological studies. However, there have been few published reports comparing the sensitivity of the rat to ototoxicants with that of the guinea pig or chinchilla.
The
Correspondence (present address) purpose of this investigation was to compare the relative sensitivity of two rat strains with that of Hartley albino guinea pigs to the ototoxic aminoglycoside gentamicin. Gentamicin sensitivity in these animals was compared with respect to ototoxicity, nephrotoxicity and body weight gain.
eateries and Methods

Reugents
Gentamicin sulfate, with a potency of 583 pg/mg, was purchased from Sigma Chemical Co. (St. Louis, MO). All other reagents were of analytical grade.
Animals
Male Sprague-Dawley rats (175-200 g. n = 20). male Fisher-344 rats (125-150 g, n = 20) and male Hartley albino guinea pigs (275-300 g, n = 12. Charles River Laboratories, Inc., Portage, Ml) were housed two per cage in hanging metal cages and given water and either guinea pig or rodent chow (Ralston Purina Co.) ad libitum. The animal quarters were maintained at 22°C on a 12 h light/dark cycle. Animals were acclimatized for one week prior to use. The treatment groups consisting of 8 Sprague-Dawley, 8 Fisher-344 rats and 4 guinea pigs were dosed subcutaneously once daily for 14 days with either 80 or 100 mg/kg of gentarnicin sulfate in saline. Gentamicin solutions were formulated at 80 and 100 mg/ml so that each rat received 1.0 ml dosing solution/kg body wt. Sealed vials of the gentamicin dosing solution were prepared and stored at 4°C until use. The four control animals of each group received saline subcutaneously. Body weights were recorded each day. Animals were observed each day for signs of vestibular toxicity: loss of righting reflex and normal gait.
Functional meusure
Brainstem auditory evoked response (BAER) t~esholds were recorded from each animal of each treatment group and all controls in a sound attenuated box on the eleventh day post-administration. The 11 day period was used to provide time for any gentamicin-induced inner ear damage to be manifested. Animals were anaesthetized with an intraperitoneal injection of ketamine hydrochloride (Ketaset, 50 mg/kg) and xylazine {Rompun, 10 mg/kg). Additional doses (l/4 original dose) were given as needed to maintain a stable state of anaesthesia. The recording electrode configuration consisted of three small (26 gauge) hypodermic needles placed under the skin below the ipsilateral right pinna (reference electrode), at the vertex (active electrode) and contralateral pinna (ground electrode). The electrodes were connected to an amplifier (Grass, model P15D, gain = 1000, filter settings = 100-3 kHz). A digital signal averager (Tracer Northern, model TN-1500) was used for signal averaging. The acoustic stimuli were presented in a closed acoustic system via a l/2 inch condenser microphone (Briiel and Kjaer) mated to a brass coupler with an 8.5 cm x 0.3 cm (i.d.) silastic tube. The tube was inserted into the left external auditory meatus. Thresholds were obtained to tone bursts with a 10 ms duration, 1.0 ms rise time, at 32, 16, 8, 4, 2, 1 and 0.5 kHz. The stimulus repetition rate was 2/s.
The stimulus intensity was decreased in 5 dB (SPL) steps, beginning at 90 dB (SPL). One set of 64 stimuli presentations was given at each intensity and 3 sets were given to determine threshold. Stimulus intensities were calibrated using a wave analyzer (Hewlett and Packard). The amplitude of wave 4 was followed as the response. The attenuator setting at which a response was last observed was recorded as the threshold. BAER data for each animal was plotted as threshold intensity, dB (SPL), versus stimulus frequency. The BAERtested animals were then prepared for histological examination.
The temporal bones from each animal of each treatment group and all controls were removed and the auditory bulla opened immediately. The round and oval windows and the apex of the cochlea were opened with a cowhom explorer (a dental instrument consisting of a handle with 2 opposite helical sharpened probes at the ends). Inner ear tissues were fixed by perfusing 2.5% glutaraldehyde in phosphate buffer (pH 7.4) through both windows. The tissue was placed in a 20 ml glass vial on a 14 inch rotor at a 30" angle and rotated at 12 rpm for 1 h. The tissue was then post-fixed with 1% 0~0, in phosphate buffer (pH 7.4) in a similar manner for 30 min. Co&leas were microdissected as described by Hawkins and Johnsson (1976) . Individual turns of the organ of Corti were mounted on glass microscope slides in glycerol. Sensory hair cells of the organ of Corti were counted using a phase-contrast microscope (Wild, equipped with a 50 x objective lens. Cytocochleograms were prepared by plotting the percentage of hair cells remaining in each individual row, millimeter by millimeter, against distance (mm) along the basilar membrane measured from the apex. BAER threshold data and cytocochleograms were compared in terms of frequency of functional change and position of the sensory hair cell loss along the basilar membrane. Average cytocochleograms were constructed by plotting the average hair cell loss in each hair cell row for each treatment group. Kidney weights were recorded at time of sacrifice and organ/body weight ratios calculated. Blood urea-nitrogen (BUN) and serum creatinine analyses (Faulkner and Ring, 1976) were performed on blood collected at sacrifice.
Statistical ana&sis
Student's t-test was used to compare means of experimental groups. Analysis of co-variance (Snedecor and Cochran, 1972) was used to compare regression lines of body weight gain data. The level of significance was P < 0.05 unless otherwise noted.
Results
Loss of outer
hair cells occurred in all gentamicin-treated animals. Average cytocochleograms show treatment-group average hair cell loss at various positions along the length of the basilar membrane, expressed as percentage of total length in millimeters measured from the apex. Average cytocochleograms are presented in Fig. 1 for each 100 mg/kg treatment group. In each animal group, hair cell loss was greater after treatment with 100 mg/kg gentamicin than after 80 mg/kg. The three animal groups exhibited different degrees of response to gentamicin.
The guinea pigs suffered more hair cell loss than the Fisher-344 rats, which, in turn, had more hair cell loss than the SpragueDawley rats. Hair cell loss after gentamicin treatment occurred in the basal region of the cochlea in all groups. The loss was greatest in the first row outer hair cells with the second and third rows showing progressively less loss. Photomicrographs of the organ of Corti from a Fisher-344 rat dosed with 100 mg/kg of gentamicin are shown in Fig.  2 . The injury begins as outer hair cell loss in the first row (Fig. 2a) . Complete hair cell loss was observed in all three rows of outer hair cells in the cochleas from animals most severely affected (Fig.  2b) .
BAER threshold elevations in gentamicintreated animals occurred at frequencies corresponding to regions of the cochlea with hair cell loss. BAER threshold elevations in treated guinea pigs extended from the 32 to 4 kHz regions. dosed subcutaneously with 100 mg/kg of gentamicin for 14 days and sacrificed on day 11 after dosing ended. IHC, OHCl. 0HC2 and 0HC3 represent inner hair cells and outer hair cell rows 1, 2 and 3. respectively. gentamicin with its associated BAER threshold data is presented in Fig. 3 . Cytocochleograms and BAER threshold graphs are presented together in Fig. 3 to facilitate comparison of the damaged region of the organ of Corti with frequency of threshold shift. The equating of a specific region of the cochlea with a specific frequency is only approximate.
Regions of elevated threshold may not exactly correspond with regions of hair cell loss. This is because of the rigid criteria for scoring an individual hair cell as present or absent. Controls of all three animal groups exhibited small amounts of hair cell loss and had measurable BAER threshold elevations. The hair cell loss in the controls was at the ends of the apicai turn and hook, which is normal for these species. T~eshoId elevations were not greater than 10 dB (SPL) and therefore elevations of less than this were not considered significant.
Measures of nephrotoxicity showed a differential response among the three animal groups. Fisher-344 rats exhibited significant increases in BUN and kidney we~~t/body weight ratios (Fig.  4) . The only ather significant increase over controls was the kidney weight/body weight ratio for the 100 mg/kg-treated guinea pigs. There were no measured nephrotoxic effects in the Sprague-Dawley rats or in serum creatinine levels in any treatment group. With respect to body weight gain, alI ge~ta~~~u-treated groups gained si~~f~c~tiy less weight than did their respective controls. The 1.00 mg/kg-treated groups gained less weight than did the 80 mg/kg-treated groups.
No sign of vestibular toxicity was evident iI> any of the treated animals.
Average cytocochleograms and BAER data for each animal group show a positive_ correlation between increasing severity of outer hair cell loss and increasing dose of gentamicin. Within each animal group, the 100 mg/kg tr~tment groups consistently exhibited greater hair cell loss than the 80 mg/kg treatment groups. The characteristic pattern. of loss (first row > second > third) and position (basal portion of the organ of Corti) of aminoglycoside-induced hair cell loss is evident in all treatment groups. The similarity in the pattern of the outer hair cell loss suggests a similar mechanism of ge~ta~~n ototoxicity in the three animal groups studied. Both functional and rno~holo~~ cal data indicate that the Hartley albino guinea pig is more sensitive to the ototoxic effect of gentamicin than either the Fisher-344 rat or the Sprague-Dawgey rat. The Fisher-344 rat is more sensitive to the ototoxic effect of gentamicin than is the Sprague-Dawley rat.
Nep~oto~city was assessed by BUN and kidney wei~t/b~y weight dete~ati~ns. The measure of kidney weight/body weight, although variable, provides an indication of an organspecific effect. BUN measurements provide an assessment of renal function: urea being cleared from the blood by the kidney. Decreases in body weight gain and increases in BUN and kidney weight/body weight ratio were measured in the Fisher-344 rats receiving 100 mg/kg of gentamitin. These results indicate that the Fisher-344 rat was the most sensitive of the three animal groups tested to the nephrotoxic effect of gentamicin. These data confirm previous Iiteratnre reports that the Fisher-344 rat is more sensitive to the nephrotoxic effect of ~no~ycoside antibiotics than the Sprague-Dawley rat (Humes et al., 1982) . However, there is not a clear correlation between the magnitudes of the ototoxic and nephrotoxic responses in the three animal groups studied. This suggests that there are other factors involved, differing in the three animals tested in this study, which affect the relationship between nephrotoxicity and ototoxicity and their relative degree of severity.
The Fisher-344 rat appears to be a useful experimental animal in the study of aminoglycoside ototoxicity because it exhibits both functional and morphological changes at the same dose levels of gentamicin as the guinea pig. The Fisher-344 rat also exhibits both ototoxicity and nephrotoxicity after gentamicin exposure, making it a useful experimental animal for examining the relationship of these two types of toxicity. However, the sensitivity of the rat to the nephrotoxic effects of gentamicin does limit its use in ototoxicity studies to dose levels at which the nephrotoxicity does not too severely compromise the health of the rat. Further studies of the factors that determine the different sensitivities of these animals to the effects of gentamicin might shed additional light on the mechanism of aminoglycoside ototoxicity.
